MDPV: Difference between revisions
>Brettmaul Added to MDPV summary. |
>Brettmaul No edit summary |
||
Line 1: | Line 1: | ||
{{stub}} | {{stub}} | ||
{| | |||
|- | |||
|- | |||
| | |||
|} | |||
Methylenedioxypyrovalerone ('''MDPV''' or commonly known as '''bath salts''') is a potent euphoric stimulant with a short history of human use. MDPV acts as a norepinephrine-dopamine reuptake inhibitor (NDRI) and possesses [[stimulant]] qualities. It was first developed in the 1960s by a team at Boehringer Ingelheim. MDPV remained an obscure stimulant until around 2004, when it was reportedly first sold as a [[designer drug]] available to the public. Products labeled as bath salts containing MDPV were previously sold as recreational drugs in gas stations and convenience stores in the United States, similar to the marketing strategy of Spice and K2 as incense. | Methylenedioxypyrovalerone ('''MDPV''' or commonly known as '''bath salts''') is a potent euphoric stimulant with a short history of human use. MDPV acts as a norepinephrine-dopamine reuptake inhibitor (NDRI) and possesses [[stimulant]] qualities. It was first developed in the 1960s by a team at Boehringer Ingelheim. MDPV remained an obscure stimulant until around 2004, when it was reportedly first sold as a [[designer drug]] available to the public. Products labeled as bath salts containing MDPV were previously sold as recreational drugs in gas stations and convenience stores in the United States, similar to the marketing strategy of Spice and K2 as incense. | ||